Developments of histamine H3-receptor antagonists

Drugs of the Future

Volumn 21, Issue 5, 1996, Pages 507-520

  Stark, Holger ^a   Schlicker, Eberhard ^b   Schunack, Walter ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 CYCLOHEXYL 1 [4 (4 IMIDAZOLYL) 1 PIPERIDYL] 1 PENTANONE; CLOBENPROPIT; CLOZAPINE; CLOZAPINE DERIVATIVE; HISTAMINE H3 RECEPTOR ANTAGONIST; MEPYRAMINE; THIOPERAMIDE; UNCLASSIFIED DRUG; ZOLANTIDINE;

ANTICONVULSANT ACTIVITY; COGNITIVE DEFECT; DRUG CONFORMATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EPILEPSY; HUMAN; NONHUMAN; PRESYNAPTIC NERVE; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVIEW; SCHIZOPHRENIA; STRUCTURE ACTIVITY RELATION;

EID: 0030015542     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Uvnas, B. (Ed.) Histamine and Histamine Antagonists. Handbook of Experimental Pharmacology, Vol 97. Springer: Berlin/ Heidelberg/New York 1991.
2. 3) of histamine receptor. Nature (London) 1983, 302: 832-7.
3. Schwartz, J.-C., Arrang, J.-M., Garbarg, M., Pollard, H., Ruat, M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991, 71: 1-51.
4. Leurs, R., Smit, M.J., Timmerman, H. Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 1995, 66: 413-63.
5. 3-receptors. In: The Histamine Receptor, Ser. Receptor Biochemistry and Methology, Vol 16. Schwartz, J.-C., Haas, H.L. (Eds.). Wiley-Liss: New York 1992, 57-72.
6. 3 receptor Prog Drug Res 1995, 45, 107-65.
7. Starke, K., Göthert, M., Kilbinger, H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 1989, 69: 864-989.
8. van der Werf, J.F, Bast, A., Bijloo, G.J., van der Vliet, A., Timmerman, H. Histamine autoreceptor assay with superfused slices of rat brain cortex and electrical stimulation. Eur J Pharrnacol 1987, 138: 199-206.
9. 2-Adrenoceptor-mediated inhibition of histamine release from rat cerebral cortex slices. Brit J Pharmacol 1988, 95: 1213-9.
10. 3-receptors. Neuroscience 1985, 15: 553-62.
11. 3-Receptors control histamine release in human brain. J Neurochem 1988, 51: 105-8.
12. 3-receptors. Nature (London) 1987, 327: 117-23.
13. Prast, H., Fischer, H.P., Prast, M., Philippu, A. In vivo modulation of histamine release by autoreceptors and muscarinic acetylcholine receptors in the rat anterior hypothalamus. Naunyn-Schmied Arch Pharmacol 1994, 350: 599-604.
14. 3-receptors. Neuroscience 1987, 23: 149-57.
15. 3 heteroreceptors. Fundam Clin Pharmacol 1994, 8: 128-37.
16. 3 receptors are involved in the control of gastric acid secretion in the conscious cat. Naunyn-Schmied Arch Pharmacol 1991, 343: 225-7.
17. 3 receptor-mediated inhibition of gastric acid secretion in conscious dogs. Naunyn-Schmied Arch Pharmacol 1993, 347: 61-5.
18. 3 ligands. Meth Find Exp Clin Pharmacol 1992, 14: 747-52.
19. 3 subtype. J Pharmacol Exp Ther 1987, 243: 874-80.
20. Tamura, K., Palmer, J.M., Wood, J.D. Presynaptic inhibition produced by histamine at nicotinic synapses in enteric ganglia. Neuroscience 1988, 25: 171-9.
21. 3 receptors regulate acetylcholine release from the guinea pig ileum myenteric plexus. Life Sci 1991, 48: PL63-8.
22. 3-receptor selective drugs on the mechanical activity of guinea-pig small and large intestine. Brit J Pharmacol 1991, 102: 179-85.
23. 3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum. Brit J Pharmacol 1992, 105: 667-74.
24. 3-receptors inhibit cholinergic neurotransmission in guinea-pig airways. Brit J Pharmacol 1989, 97: 13-5.
25. 3-receptors on cholinergic nerves in human airways. Eur J Pharmacol 1989, 163: 383-6.
26. Ichinose, M., Barnes, P.J. Histamine H3-receptors modulate nonadrenergic noncholinergic neural bronchoconstriction in guinea-pig in vivo. Eur J Pharmacol 1989, 174: 49-55.
27. Hutchinson, R.W., Hey, J.A Pharmacological characterization of the inhibitory effect of (R)-α.-methylhistamine on sympathetic cardiopressor responses in the pithed guinea-pig. J Autonom Pharmacol 1994, 14: 393-402.
28. 3 -receptors in myocardial ischemia: Their role as regulators of exocytotic norepinephrine release. J Pharmacol Exp Ther 1994, 271: 1259-66.
29. 3-receptors in the human heart. Circ Res 1995, 77: 206-10.
30. 3 vasodilator mechanisms in the guinea pig ileum. Gastroenterology 1995, 108: 712-8.
31. 3 receptors inhibit sympathetic modulation of airway microvascular leakage in allergic guinea pigs. Eur J Pharmacol 1994, 254: 283-6.
32. Matsubara, T., Moskowitz, M.A., Huang, Z. UK-14,304, R(-)-α-methylhistamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms. Eur J Pharmacol 1992, 224: 145-50.
33. 3-receptors inhibit neurogenic microvascular leakage in airways. J Appl Physiol 1990, 68:21-5.
34. 3 receptors are not involved in the regulation of rat gastric secretion. Pharmacology 1992, 44: 190-5.
35. 3-antagonist). Jpn J Pharmacol 1993, 62: 75-9.
36. 3-receptors in the regulation of anaphylactic histamine release from isolated rat peritoneal mast cells. Jpn J Pharmacol 1994, 66: 173-80.
37. 3-receptors on the spontaneous and ConA induced histamine release from human adenoidal mast cells. Agents Actions 1991, 33: 67-70.
38. 3 receptors. Allergy 1991, 46: 626-31.
39. 3-receptor modulation in rat lung and spleen. Clin Sci 1994, 87: 151-63.
40. 3 receptor heterogeneity. Naunyn-Schmied Arch Pharmacol 1994, 350. 375-9.
41. 3 receptors in isolated rabbit gastric glands. Amer J Physiol 1992, 262: G56-61.
42. 3 receptor negatively coupled to phosphoinositide turnover in the human gastric cell line HGT1. J Biol Chem 1992, 267: 25315-20.
43. Ambache, N., Killick, S W., Zar, M.A. Antagonism by burimamide of inhibitions induced by histamine in plexus-containing longitudinal muscle preparations from guinea-pig ileum. Brit J Pharmacol 1973, 48: 362-3P.
44. 3 receptor. Agents Actions 1990, 30: 13-23
45. Arrang, J.-M., Garbarg, M., Quach, T.T., Trung Tuong, M.D , Yeramian, E., Schwartz, J.-C. Action of betahistine at histamine receptors in the brain. Eur J Pharmacol 1985, 111: 73-84.
46. 3-receptors in the brain. Eur J Pharmacol 1988, 157: 31-5.
47. 3 receptors. Psychopharmacology 1994, 116: 464-8.
48. 3 receptor in the rat brain. Brit J Pharmacol 1995, 114: 1523-4.
49. Arrang, J.-M., Garbarg, M., Lancelot, J.-C.M., Lecomte, J.-M., Robba, M.F., Schwartz, J.-C. 4-Imidazolylpiperidines, their process of preparation and their therapeutic application. EP 197840
50. 3 receptor revealed. Brit J Pharmacol 1995, 116: 2315-21.
51. Grimmet, M.R. Advances in imidazole chemistry. Adv Heterocycl Chem 1980, 27: 241-326.
52. Elz, S., Schunack, W. An alternative synthesis of homohistamine and structurally related (imidazol-4-yl)alkylamines. Z Naturforsch 1987, 42b: 238-42.
53. Pätzel, M., Liebscher, J. Application of the ring-chain transfer concept to the synthesis of 4-(ω-aminoalkyl)imidazole analogues of histamine. J Org Chem 1992, 57: 1831-3
54. Kivits, G.A.A., Hora, J. A convenient preparation of 3-(1H-imidazol-4-yl)propanol. J Heterocycl Chem 1975, 12: 577.
55. Koehler, U., Kahl, T-M., Neuhauser, H., Siegel, H., Kroener, M. Methods for the preparation of 4-substituted imidazoles. EP 0562345A2.
56. Vollinga, R.C , Menge, W.M.P.B., Timmerman, H. A new convenient route for the synthesis of 4(5)-(ω)-aminoalkyl)-1H-imidazoles. Reel Trav Chim Pays-Bas 1993, 112: 123-5.
57. Chibata, I., Tosa, T, Sato, T., Yanamoto, K. Urocanic acid and D-histidine production by an immobilized microbe. JP 7461390.
58. Sellier, C., Buschauer, A., Elz, S., Schunack, W. Synthesis of (Z)- and (E)-3-(1H-imidazol-4-yl)-2-propenamine and some 3-(1H-imidazol-4-yl)propanamines. Liebigs Ann Chem 1992: 317-23.
59. Schwartz, J.-C., Arrang, J.-M., Garbarg, M. et al. Novel imidazole derivatives, their preparation and therapeutic application. WO 93/14070.
60. 3-receptor antagonists. Eur J Med Chem 1994, 29: 695-700.
61. 3-receptor antagonists of the amide type. Eur J Pharm Sci 1995, 3: 95-104.
62. 2-agonists. Drugs Fut 1990, 15: 919-33.
63. 3-receptor antagonists. Bioorg Med Chem Lett 1994, 4: 2907-12.
64. 3-receptor histamine antagonists. J Med Chem 1995, 38: 3342-50.
65. 3 receptor antagonists: The effect of chain length, variation of the alkyl spacer and modifications of the N-thiourea substituent. J Med Chem 1995, 38: 2244-50.
66. 3 receptor. J Med Chem 1996, 39: 1220-6.
67. 3 receptor antagonists with high in vitro and oral in vivo activity, J Med Chem 1996 39: 1157-63.
68. 3-receptor antagonist in vitro and in vivo activity. Bioorg Med Chem Lett, submitted.
69. 3-receptor antagonists with benzyl ether structure or related moieties: Synthesis and structure-activity relationships Arch Pharm (Weinheim), in press.
70. 3-receptor antagonists. Eur J Pharm Sci 1994, 2: 139.
71. 3-receptor agonist. J Pharmacol Exp Ther 1992, 263: 304-10.
72. 3 antagonist thioperamide. Tetrahedron 1995, 51: 13447-54
73. Arrang, J.-M., Garbarg, M., Lancelot, J.-C.M., Lecomte, J.-M., Robba, M.F., Schwartz, J.-C. Novel substituted 4-(4-imidazolyl)piperidines, process of preparation and their therapeutic application. EP 494010.
74. 3-receptor antagonists and therapeutic uses thereof. WO 93/20061.
75. Durant, G J., Khan, A.M. Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists WO 93/20062.
76. 3 receptor antagonist: In vitro and in vivo studies J Pharmacol Exp Ther 1995, 275: 598-604.
77. 3-receptor antagonists: Synthesis and evaluation of formamidine and S-methylisothiourea derivatives. 208th ACS Meet (August 21-25, Washington, DC) 1994, Abst MEDI 117.
78. 3-receptor affinity. Eur J Med Chem 1995, 30: 881-9.
79. 3 antagonist, 4(5)-(5-aminopentyl)-1H-imidazole. J Med Chem 1995, 38: 266-71
80. 3 receptor model. Naunyn Schmied Arch Pharmacol 1993, 348: 498-503.
81. 3 receptor models. Brit J Pharmacol 1994, 112: 1043-8, and Erratum. Brit J Pharmacol 1994, 113:657.
82. 3 receptor antagonists. 10th Camerino-Noordwijkerhout Symp, Perspect Recept Res (Sept. 10-14, Camerino) 1995, Abst P89.
83. Pomponi, S.A., Gullo, V.P., Horan, A.C., Patel, M.G., Coval, S. Anti-allergy agent. US 5217986.
84. 3 antagonist from the marine sponge Verongula gigantea. J Natural Prod 1994, 57: 175-7.
85. 3-receptor antagonists. WO 95/14007.
86. 3-receptor antagonists. Arch Pharm (Weinheim) 1994, 328: 445-50.
87. 3-receptor antagonists. Arch Pharm (Weinheim) 1994, 328: 469-72.
88. 3-receptor ligands. II Farmaco Ed Sci 1992, 47: 1343-65
89. Mörsdorf, P., Schickaneder, H , Pfahlert, V., Engler, H , Buschauer, A., Schunack, W. Guanidinocarboxylic esters, processes for their preparation and therapeutic drugs containing these compounds. EP 302164.
90. Schwartz, J.-C. et al. Personal communications.
91. 3-receptor antagonist, in rats. J Pharm Pharmacol 1994, 46: 209-12.
92. Bordi, F., Mor, M., Plazzi, P.V , Silva, C , Caretta, A., Morini, G. HPLC detection of thioperamide from biological samples and its determination in rat blood and brain after systemic application. II Farmaco Ed Sci 1992, 47: 1093-103.
93. 3 receptor antagonists of histamine. J Mol Struct 1993, 280. 5-15.
94. 3-receptor affinity of benzothiazole derivatives of thioperamide. II Farmaco Ed Sci 1994, 49: 153-66.
95. Vinter, J.G., Trollope, K.I. Multiconformational composite molecular potential fields in the analysis of drug action. I. Methodology and first evaluation using 5-HT and histamine action as examples. J Comput-Aided Mol Design 1995, 9: 297-307.
96. 3 receptor heterogeneity? Naunyn-Schmied Arch Pharmacol 1996, 353: 482-8.
97. 3-receptor. Eur J Med Chem 1992, 27: 511-7.
98. 3-receptor ligands. J Pharm Belg 1995, 50: 179-87.
99. Kenakin, T. Pharmacologic Analysis of Drug-Receptor Interaction, Second Edition. Raven Press: New York 1993.
100. 3 receptor binding sites. J Labelled Compd Radiopharm 1992, 31: 781-6.
101. 125I]-iodophenpropit, to rat brain. Brit J Pharmacol 1994, 113: 355-62.
102. 3 receptors. J Pharmacol Exp Ther 1994, 271: 452-9.
103. 3 receptors, Inflamm Res 1995, 44: 296-300.
104. 3H](R)α -methylhistamine binding to rat tissues. Jpn J Pharmacol 1994, 65: 107-12.
105. 3 receptor antagonists with carbon-11 using on-line methylation system: Potential radiopharmaceuticals for PET studies. J Labelled Compd Radiopharm 1994, 35: 520.
106. 3) visualized in the brain of human and non-human primates Brain Res 1990, 526: 322-7.
107. Prell, G.D., Green, J.P., Kaufmann, C.A. et al. Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: Their relationships to levels of other aminergic transmitters and ratings of symtoms. Schizophr Res 1995, 14: 93-104.
108. 1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol Psychiat 1991, 30: 349-56.
109. 3 receptors is not shared by its two major metabolites and by structurally related and unrelated neuroleptics. Naunyn-Schmied Arch Pharmacol 1996, 353: 290-4.
110. Baldessarini, R J., Centorrino, R, Flood, J.G., Volpicelli, S.A , Huston-Lyons, D., Cohen, B.M. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 1993, 9: 117-24.
111. 3 receptor antagonist, on electrically induced convulsions in mice. Eur J Pharmacol 1993, 234: 129-33.
112. Yokoyama, H., Onodera, K., Maeyama, K. et al. Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice. Eur J Pharmacol 1994. 260: 23-8.
113. Onodera, K., Yamatodani, A., Watanabe, T., Wada, H. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 1994, 42: 685-702.
114. 3 antagonists on learning and memory processes. Symp Histamine Neurosci Res Group, Satel Symp 25th Annu Meet Soc Neurosci (Nov 11, San Diego) 1995.
115. 3 receptor antagonist thioperamide improves cognition and enhances hippocampal acetylcholine release in vivo. Soc Neurosci Abstr 1993, 19: 1813.
116. 3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice. Pharmacol Biochem Behav 1995, 50: 321-5.
117. 3-receptor antagonist, on a scopolammeinduced learning deficit using an elevated plus-maze test in mice. Life Sci 1995, 57: 2137-44.
118. Panula, P., Kuokkanen, K., Relja, M. et al. Significant changes in the human brain histaminergic system in Alzheimer's disease. Soc Neurosci Abstr 1995, 21: 1977.
119. 4 Neuropsychopharmacology 1992, 7: 261-84.
120. 3 antagonist, GT-2016 New Perspectives in Histamine Research, Satellite Symp XIIth Int Cong Pharmacol (Elkhorn-Winnipeg, Canada, July 20-24) 1994